Discontinued — last reported Q4 '21
Xylem Accrued Contingent Liabilities remained flat by 0.0% to $4.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $4.00M to $4.00M. Over 5 years (FY 2020 to FY 2025), Accrued Contingent Liabilities shows a downward trend with a -7.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase suggests higher legal or operational risk, while a decrease may indicate the resolution of past uncertainties.
This represents the estimated financial obligations arising from past events where the outcome is uncertain but probable...
Peers typically disclose these in legal contingencies footnotes; high levels relative to equity can signal significant litigation exposure.
accrued_contingent_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.00M | $5.00M | $4.00M | $5.00M | $5.00M | $4.00M | $12.00M | $14.00M | $18.00M | $15.00M | $6.00M | $6.00M | $4.00M | $4.00M | $7.00M | $4.00M | $4.00M | $4.00M |
| QoQ Change | — | +0.0% | -20.0% | +25.0% | +0.0% | -20.0% | +200.0% | +16.7% | +28.6% | -16.7% | -60.0% | +0.0% | -33.3% | +0.0% | +75.0% | -42.9% | +0.0% | +0.0% |
| YoY Change | — | — | — | +0.0% | +25.0% | — | — | +180.0% | +260.0% | +275.0% | -50.0% | -57.1% | -77.8% | -73.3% | +16.7% | -33.3% | +0.0% | +0.0% |